Chelsea Counsel Company’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$234K Sell
1,960
-135
-6% -$17.7K 0.1% 97
2025
Q4
$285K Hold
2,095
0.12% 91
2025
Q3
$309K Sell
2,095
-100
-5% -$13.9K 0.14% 90
2025
Q2
$284K Hold
2,195
0.14% 90
2025
Q1
$262K Hold
2,195
0.14% 91
2024
Q4
$255K Sell
2,195
-50
-2% -$6.32K 0.13% 89
2024
Q3
$303K Hold
2,245
0.15% 85
2024
Q2
$304K Buy
2,245
+400
+22% +$54.4K 0.15% 85
2024
Q1
$238K Hold
1,845
0.14% 82
2023
Q4
$211K Hold
1,845
0.11% 92
2023
Q3
$168K Hold
1,845
0.09% 104
2023
Q2
$208K Sell
1,845
-500
-21% -$52.9K 0.1% 97
2023
Q1
$246K Hold
2,345
0.12% 93
2022
Q4
$259K Sell
2,345
-300
-11% -$31.4K 0.13% 88
2022
Q3
$231K Sell
2,645
-170
-6% -$15.5K 0.14% 77
2022
Q2
$220K Sell
2,815
-320
-10% -$26.4K 0.11% 93
2022
Q1
$267K Hold
3,135
0.12% 90
2021
Q4
$376K Buy
3,135
+1,040
+50% +$129K 0.16% 79
2021
Q3
$259K Buy
+2,095
New +$270K 0.12% 86

Other funds holding XYL

Chelsea Counsel Company's XYL Position: Q1 2026 in Review

Chelsea Counsel Company reduced its Xylem (XYL) stake by 6.4% in Q1 2026, selling an estimated $17.7K and leaving 1,960 shares worth $234K. The position accounts for 0.1% of the portfolio, ranked #97.

Chelsea Counsel Company first reported a position in XYL in Q3 2021 and has held it in 19 quarters since. The position peaked at $376K in Q4 2021. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Chelsea Counsel Company held 1,960 shares of Xylem worth $234K as of Q1 2026.
  • Chelsea Counsel Company sold 135 Xylem shares in Q1 2026, an estimated $17.7K.
  • Xylem made up 0.1% of Chelsea Counsel Company's portfolio in Q1 2026, its #97 holding.
  • Chelsea Counsel Company first reported a position in Xylem in Q3 2021 and has held it in 19 quarters since.
  • Chelsea Counsel Company's Xylem position peaked at $376K in Q4 2021.
  • 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.